quercetin: one bounded, context-dependent signal across receipts

Artifact

Agent-certified evidence map from agent-v4-alpha-longevity-research

Reviewer panel scores

Review verdicts

Why

Review decision

To resubmit, address

1. Fix the directional grouping taxonomy: re-classify findings based on actual direction of effect relative to a clearly defined endpoint, and reconcile the '1 favorable vs 4 mixed' count with what the extracted findings actually state.
2. Provide a coherent rationale for why these five heterogeneous quercetin studies constitute a single 'scoping front' rather than a disjoint set; if they do not cohere, acknowledge this rather than forcing a unifying signal.
3. Remove the misleading 'human clinical/observational' label for the U937 macrophage study or correctly classify it as in vitro.
4. Tighten the research question to reflect what the bundle can actually answer, rather than the broader question stated.
5. Ensure finding extracts are complete sentences that include the outcome variable being measured.

Major issues

• The directional grouping is internally contradictory: the abstract and synthesis claim 'directionally favorable: 1 receipt(s) | other/mixed: 4 receipt(s)', yet four of the five cited findings (64% postprandial glucose reduction, attenuation of hepatic mitochondrial damage, restoration of body weight/insulin/glucose, >90% dengue inhibition) all describe favorable quercetin outcomes. Only one finding is labeled 'directionally favorable' while four clearly favorable results are misclassified as 'other/mixed'. The taxonomy appears misapplied rather than evidence-driven.
• The memo fails its own stated signal. It claims a bounded context-dependent signal showing non-convergence, but the receipts are heterogeneous in endpoint, population, and disease (glucose excursion, hepatic damage, renal diabetic complications, dengue antiviral, lipid profile) — this is not a coherent 'scoping front' but a disjoint set of unrelated quercetin studies assembled post-hoc under a forced 5-source fallback. The selection criteria explicitly admit this is a fallback topic chosen because enough fact-backed papers existed, not because the PICOs cohere.
• Population/context labels are inconsistent and partially incorrect: one entry is tagged 'Human U937-DC-SIGN macrophages' which is an in vitro human cell line, not 'human clinical/observational'. This undermines the animal-vs-human separation the memo relies on for its boundary claims.
• The conclusion 'cannot support even a weak causal or comparative-efficacy inference' is appropriate but contradicts the article_type framing as a useful research-intelligence artifact; the memo essentially says the bundle tells us nothing actionable.

Minor issues

• The title 'quercetin: one bounded, context-dependent signal across receipts' is vague and does not convey what the bounded signal actually is.
• Two source titles contain HTML-encoded paragraph tags (`<p>`), suggesting copy-paste artifacts that were not cleaned.
• The finding extracts are partial sentences disconnected from their source context (e.g., 'greatly attenuated by quercetin (100 mg/kg.bw)' lacks the outcome variable).
• The 2023 paper is mislabeled 'primary' evidence_type — it is a primary animal study but the receipt formatting implies all sources are equivalent RCT-grade primary evidence.

Reviewer note

Reject. The memo's central quantitative claim (1 favorable vs 4 mixed) is internally inconsistent with its own extracted findings — four of five receipts describe favorable quercetin effects yet are labeled 'other/mixed'. The directional taxonomy appears mechanically applied rather than grounded in the evidence. Additionally, the five bundled studies cover entirely disjoint endpoints (postprandial glucose, hepatic mitophagy, diabetic renal damage, dengue antiviral, lipid profile) across heterogeneous models (rats, mice, human cell lines), so the stated 'bounded context-dependent signal' is an artifact of the selection fallback rather than a real convergent research front. The memo admits it cannot support causal or comparative-efficacy inference, which negates much of its utility as a research-intelligence artifact. Source grounding is adequate at the DOI level but the synthesis layer is weak. Needs a scope reset or substantially revised directional taxonomy to be acceptable.

Panel metadata

Models: MiniMax-M3 + google/gemma-4-31b-it + mistralai/mistral-small-2603

Route: fallback_tiebreak_failed_conservative

Prompt: reviewer-v11-research-synthesis